SigmaMAb Antibody Drug Conjugate (ADC) Mimic Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Poster: Antibody Drug Conjugate Mimic Enables LC-MS Method Development Without Risk

Poster: LC-UV-MS Method Development for Antibody Drug Conjugates Using a Non-Toxic ADC-Mimic

Poster: LC-MS Method Development for Antibody Drug Conjugates Using a Non-Toxic ADC Mimic

Allgemeine Beschreibung

SigmaMab Antibody Drug Conjugate (ADC) Mimic, is a non-toxic drug mimic that is utilized as a standard for mass spectrometry and high performance liquid chromatography. The ADC Mimic conjugates SigmaMab (MSQC4), an IgG1 monoclonal antibody, to dansyl fluorophores via an LC-SMCC crosslinker. This dansyl-LC-SMCC attachment serves as the substitution for the toxic payload of a real ADC.

The ADC Mimic allows for safer and more consistent testing, making it the optimal product over real ADCs. It is also a more affordable product compared to real ADCs. With the help of this non-toxic product, LC-MS processes can be developed in a safer environment.

SigmaMAb Antibody Drug Conjugate (ADC) Mimic Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

SigmaMAb Antibody Drug Conjugate (ADC) Mimic Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Sigma-Aldrich	021-61415566 800-8193336	orderCN@merckgroup.com	China	51456	80
Merck KGaA	(+86) 21 2033 8288	sigmaname@qq.com	CHINA	292394	58

---

• SigmaMAb Antibody Drug Conjugate (ADC) Mimic